Usefulness of aMAP Risk Score for Predicting Recurrence after Curative Treatment for Hepatocellular Carcinoma within Milan Criteria

Usefulness of aMAP Risk Score for Predicting Recurrence after Curative Treatment for Hepatocellular Carcinoma within Milan Criteria

Introduction: The aMAP score is a prediction model for hepatocellular carcinoma (HCC) risk in chronic hepatitis patients. This study was conducted to elucidate the utility of this model for predicting initial recurrence of HCC in patients within the Milan criteria after undergoing curative treatment...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncology 2023-09, Vol.101 (9), p.575-583
Hauptverfasser: Ohama, Hideko, Hiraoka, Atsushi, Tada, Fujimasa, Kato, Kanako, Fukunishi, Yoshiko, Yanagihara, Emi, Kato, Masaya, Saneto, Hironobu, Izumoto, Hirofumi, Ueki, Hidetaro, Yoshino, Takeaki, Kitahata, Shogo, Kawamura, Tomoe, Kuroda, Taira, Suga, Yoshifumi, Miyata, Hideki, Hirooka, Masashi, Abe, Masanori, Matsuura, Bunzo, Ninomiya, Tomoyuki, Hiasa, Yoichi
Format: Artikel
Sprache:eng
Schlagworte:
Clinical Study
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Introduction: The aMAP score is a prediction model for hepatocellular carcinoma (HCC) risk in chronic hepatitis patients. This study was conducted to elucidate the utility of this model for predicting initial recurrence of HCC in patients within the Milan criteria after undergoing curative treatment. Methods: Patients with naïve HCC within the Milan criteria (n = 1,020) and treated from January 2000 to August 2022 were enrolled. The cohort was divided into two groups according to the aMAP score (high ≥60, low
ISSN:0030-2414
1423-0232
DOI:10.1159/000530987